Mirati Therapeutics, Inc. (MRTX) News Headlines

▮ More

Date

Headline

1/14/2020 4:02:44 PM Mirati Therapeutics Closes Public Offering Of 3.54 Mln Shares Of Its Common Stock

1/9/2020 10:06:24 PM Mirati Therapeutics Prices Underwritten Public Offering Of 3.08 Mln Shares At $97.50/shr

1/8/2020 4:07:31 PM Mirati Therapeutics Announces Proposed Public Offering Of Common Stock

11/10/2019 10:48:43 PM LPCN Awaits FDA Word, NKTR On Track, All's Well With Five Prime's FPT155

10/29/2019 9:44:44 PM Today's Top 5 Gainers In Healthcare Sector (ISEE, CYCN, STOK…)

10/29/2019 3:54:45 AM AZN's POSEIDON Has Poise, MRTX On The Move, MOR Drops Atopic Dermatitis Trial

8/15/2019 4:35:20 PM Mirati Therapeutics Appoints Jenny Gizzi As VP, Human Resources

7/1/2019 4:43:13 PM Mirati Therapeutics Appointa Julie Cherrington To Board Of Directors

6/27/2019 4:21:53 PM Mirati Therapeutics Closes Public Offering Of Common Stock

6/25/2019 8:33:54 AM Mirati Therapeutics Prices Public Offering Of 2.10 Mln Shares At $97.00/shr

6/24/2019 4:02:35 PM Mirati Therapeutics Announces Proposed Public Offering Of Common Stock

6/3/2019 10:20:10 PM 6 Top Gainers In Pharma Sector (MRTX, NK, GNCA...)

4/29/2019 4:12:58 PM Mirati Therapeutics Q1 Loss/share $1.17 Vs. Loss $0.51 Year Ago

2/28/2019 4:28:26 PM Mirati Therapeutics Q4 Loss/share $0.87 Vs. Loss $0.67 Year Ago

2/20/2019 12:13:18 AM FDA Nod For NVO's Hemophilia A Drug, ICPT's NASH Trial Hits Goal, NVTA Abuzz

2/19/2019 4:18:01 PM Mirati Therapeutics Appoints Faheem Hasnain As Chairman Of The Board

1/17/2019 1:00:29 AM FDA Panel Nod For Osteoporosis Drug, PTIE Gets Research Funding, ALDR On Watch

1/16/2019 8:57:07 PM Mirati Therapeutics Prices Underwritten Public Offering Of 1.61 Mln Shares At $62.00/shr

1/16/2019 4:02:08 PM Mirati Therapeutics Announces Proposed Public Offering Of Common Stock

1/10/2019 8:15:01 PM 6 Top Gainers In Healthcare Sector (PLXP, AMRN, MRTX...)